Efficacy and Safety of Actonel ® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Risedronate Sodium 35 MG [Actonel];   Drug: Calcium Vitamin D combination Sponsor:   Dong-A ST Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
Conditions:   Postmenopausal Osteoporosis;   Hypovitaminosis D;   Hyperparathyroidism Interventions:   Drug: Risedronate;   Drug: Vitamin D Sponsors:   Hospital Regional 1o de Octubre;   National Polytechnic Institute, Mexico;   Universidad Nacional Autonoma de Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials